University of Warmia and Mazury
Olsztyn, Poland

The University of Warmia and Mazury in Olsztyn was established on 1 September 1999, in accordance with the new Statute of Sejm signed by the President of the Republic of Poland, Aleksander Kwaśniewski, as well as the Minister of National Education, Mirosław Handke, in August of the same year. Its first rector became prof. dr. hab. Ryszard Górecki. The Faculty of Theology was prescribed with the agreement between Polish Episcopate and the government, in the presence of Cardinal Józef Glemp among others. In October the first academic year was inaugurated.The core structure of the University was based upon the agreement between the academic senate of three institutions of higher learning already established in the city: the Academy of Agriculture and Technology, the Pedagogical Institute, and the Warmia Institute of Teology.The University has 16 faculties, out of which 8 hold full academic rights and therefore entitle the university to operate as an autonomous unit. Wikipedia.

Time filter
Source Type

Zalecki M.,University of Warmia and Mazury
Journal of Chemical Neuroanatomy | Year: 2012

The pylorus, an important part of the digestive tract controlling the flow of chyme between the stomach and the duodenum, is widely innervated by intrinsic and extrinsic nerves. To determine the locations of postganglionic sympathetic perikarya that innervate the pylorus of the domestic pig, a retrograde tracing method with application of Fast Blue tracer was used. All positive neuronal cell bodies (ca. 1750) were found in the celiac-cranial mesenteric ganglion complex (CSMG), however, the coeliac poles of this complex provided the major input to the pylorus. Afterwards, the immunohistochemical staining procedure was applied to determine biologically active substances expressed in the FB-labeled perikarya. Approximately 77% of the FB-positive cell bodies contained tyrosine hydroxylase (TH), 87% dopamine β-hydroxylase (DβH), 40% neuropeptide Y (NPY), 12% somatostatin (SOM) and 7% galanin (GAL). The presence of all these substances in the ganglion tissue was confirmed by RT-PCR technique. Double immunocytochemistry revealed that all of the TH-positive perikarya contained DβH, about 40% NPY, 12% SOM and 8% GAL. Additionally, all above-cited immunohistochemical markers as well as VIP, PACAP, ChAT, LEU, MET, SP and nNOS were observed within nerve fibers associated with the FB-positive perikarya. Immunocytochemical labeling of the pyloric wall tissue disclosed that TH+, DβH+ and NPY+ nerve fibers innervated ganglia of the myenteric and submucosal plexuses, blood vessels, both muscular layers and the muscularis mucosae; nerve fibers immunoreactive to GAL mostly innervated both muscular layers, while SOM+ nerve fibers were observed within the myenteric plexus.Presented study revealed sources of origin and immunohistochemical characteristics of the sympathetic postganglionic perikarya innervating the porcine pylorus. © 2011 Elsevier B.V.

The distribution and chemical coding of neurons supplying urinary bladder in the male pig were studied in the sympathetic chain ganglia, inferior mesenteric ganglia and anterior pelvic ganglia. The combined retrograde tracing and immunohistochemistry for tyrosine hydroxylase (TH), dopamine beta-hydroxylase (DBH), neuropeptide Y (NPY), somatostatin (SOM), galanin (GAL), vasoactive intestinal polypeptide (VIP), nitric oxide synthase (NOS), calcitonin gene-related peptide (CGRP), substance P (SP), choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) were applied in the experiment. Bladder-projecting neurons were found in all the ganglia studied. The majority of sympathetic ganglia neurons (inferior mesenteric ganglia and sympathetic chain ganglia) expressed immunoreactivity (IR) to DBH. In sympathetic chain ganglia these neurons simultaneously expressed NPY, GAL or VAChT, while in inferior mesenteric ganglia they contained NPY, SOM and/or GAL. A small number of these bladder-projecting neurons was VAChT-IR and some contained NPY. In the pelvic ganglia bladder-projecting neurons formed two populations: DBH- and VAChT-IR. Some of DBH-IR neurons contained IR to NPY, SOM or GAL, while VAChT-IR neurons were NPY-, SOM- or NOS-IR. The results indicate that sympathetic ganglia contain mainly adrenergic neurons, while pelvic ganglia contain both adrenergic and cholinergic neurons. All these neurons contain typical combinations of neuropeptides. © 2013 Springer Science+Business Media New York.

Agency: European Commission | Branch: H2020 | Program: SGA-CSA | Phase: INNOVATION | Award Amount: 80.50K | Year: 2015

Main objective of the project is increasing efficiency and effectiveness of R&D and innovation investments which will contribute to smart growth in EU countries. The project also focuses on strengthening of collaboration between different actors important in innovation chain. Innovation development among SMEs (99% of enterprises in EU) is crucial to smart and sustainable growth. Specific objectives will be implemented by Enterprise Europe Network East Poland Consortium. Project duration is forseen for 24 months and will end by the end of December 2016. Within the Consortium 10 WP 1 Key account management services packages and 36 WP2 Enhancing the innovation management capacity of SMEs service packages are foreseen. Number of service packages planned is based on economic indicators and Enterprise Europe Network experts experience. The Enterprise Europe Network is the biggest network in Europe that provides high quality and specialised support for SMEs. The Network was established in 2008 and will still be operating in years 2015-2020, thus has great potential to provide additional support services for companies with possibilities for international growth and innovation implementation. Five Enterprise Europe Network partners in lubelskie, podlaskie and warminsko-mazurskie voivodeship are ready to participate in the action with the following input: Lublin Development Foundation - P1 - 2 service packages, Lublin University of Technology - P2 - 12 service packages Podlaska Regional Development Foundation P3 - 10 service packages University of Warmia and Mazury in Olsztyn - P4 - 12 service packages Warmia and Mazury Regional Development Agency - P5 - 10 service packages The consortium management structure will be based on Enterprise Europe Network East Poland. WP1 and WP2 services will be provided in each region covered by the Consortium.

Agency: European Commission | Branch: FP7 | Program: CSA-SA | Phase: KBBE.2013.2.3-02 | Award Amount: 4.41M | Year: 2013

In the European Union, Small and Medium Enterprises (SMEs) of the food sector are increasingly under pressure due to developing open markets, increasing demand of standardized and price competitive food products by the consumers, rising importance of large retailers and challenges in obeying governmental regulations. This raises the risk of losing many traditional foods as well as traditional processing techniques which are applied by SMEs using regional raw materials and often have a role in the cultural identity of regions. In urban centers in Europe, groups of consumers are increasingly demanding traditional, local and/or organic food productions as food poisoning cases and the dispute on GMO undermined public confidence on industrial food producing systems. To reach these markets, SMEs of traditional foods must extend their skills in modern as well as competitive marketing and production techniques to comply with existing European regulations and to promote the aspects of their products related to nutrition and health. To support these traditional SMEs, a knowledge transfer network shall be established with the focus on different food product sectors: Grains, fishes, fruits, vegetables and mushrooms. These food sectors are traditional, healthy foodstuffs which are essential for a balanced nutrition. To support traditional SMEs in these food sectors, a European network will interlink researchers, knowledge transfer organizations and associations of SMEs on European, national and region levels. The network will act as a mediator of information about innovations in production and marketing of traditional food, will foster entrepreneurship in the sector of traditional food producers and researchers as well as will develop strategic research and innovation agendas for the traditional food sectors to be competitive on future markets.

Agency: European Commission | Branch: H2020 | Program: RIA | Phase: ISIB-05-2014 | Award Amount: 10.81M | Year: 2015

The COSMOS proposal aims to reduce Europes dependence on imported coconut and palm kernel oils and fatty acids and castor oil as sources for medium-chain fatty acids (MCFA, C10C14) and medium-chain polymer building blocks. These are needed by the oleochemical industry for the production of plastics, surfactants, detergents, lubricants, plasticisers and other products. In COSMOS, camelina and crambe will be turned into profitable, sustainable, multipurpose, non-GMO European oil crops for the production of oleochemicals. Seed properties will be screened and optimised through genetic techniques aiming at high yield, low resource inputs, optimization of the value generated from vegetative tissues and fatty acid profiles adapted to industrial needs. Large-scale field trials will be performed at different locations in Europe to assess the potential of the crops in terms of cultivation practices, seed yield, oil content, ease of harvesting, and resource inputs. Extracted oils will be fractionated into various fatty acid types (monounsaturated versus polyunsaturated) by selective enzyme technologies and extraction processes. The monounsaturated long-chain fatty acids so obtained will be converted to MCFA and high-value building blocks for bio-plastics and flavour and fragrance ingredients through chemical and enzymatic chain cleavage processes. The 3-rich PUFA fraction will be purified for use in food and feed ingredients. Vegetative tissues such as straw, leaves and press cake will be fed to insects producing high-value proteins, chitin and fats. Insect fats and proteins will be isolated and prepared for use in food and feed products. The overall economic, social and environmental sustainability as well as life cycle of the whole value chain will be assessed. The impact of the project for Europe will be assessed in terms of value chain potentials for value creation and number of jobs that can be created.

Agency: European Commission | Branch: H2020 | Program: RIA | Phase: FETOPEN-1-2014 | Award Amount: 2.46M | Year: 2015

The ageing society and demographic change is one of the major challenges which Europe is facing now, and even more so in the future. Mastering this challenge requires radically new diagnostic and therapeutic treatments as key factors in achieving the healthy well-being of European citizens. Molecular imaging (MI) plays a pivotal role in diagnosis, understanding of disease and in the development of effective treatments. CONQUER will explore a fundamentally new contrast mechanism with the potential to push magnetic resonance imaging (MRI) far beyond its limits towards a powerful MI modality. This will be achieved by exploiting the cross relaxation between 1H and large quadrupolar nuclei (QN) for contrast agent (CA) design. The main objective is to synthesize bio-compatible QN compounds and nano-particles (NPs), high efficiency and manifold degrees of freedom in the design of smart properties, such as the ability to switch the contrast on and off by changing the magnetic field or chemical binding (e.g. targeting). The NPs will be tailored based on quantum-mechanical simulations. Sensitivity and contrast switching will be demonstrated with MRI in cell cultures. This highly interdisciplinary project combines expertise in quantum physics, chemical and biomedical engineering, material characterisation as well as nanotoxicology. Today, European scientists and companies are already leading global players in CA development. CONQUER will significantly fertilise this field and lay the scientific foundations for a new technology by providing theoretical groundwork, synthesis guidelines, imaging instrumentation and toxicological references. These results will be actively transferred to academia and industry as well in order to strengthen European competitiveness. The combination of a so far unexploited quantum-mechanical phenomenon and cutting-edge imaging technologies has the potential to create MI solutions with significant impact.

Agency: European Commission | Branch: H2020 | Program: RIA | Phase: PHC-11-2015 | Award Amount: 6.60M | Year: 2016

Many diseases are inadequately diagnosed, or not diagnosed early enough by current imaging methods. Examples of unmet clinical needs arise in thromboembolic disease, osteoarthritis, cancer, sarcopenia, and many more areas. Our solution, Fast Field-Cycling (FFC) MRI, can measure quantitative information that is invisible to standard MRI. FFC scanners switch magnetic field while scanning the patient, obtaining new diagnostic information. FFC-MRI has been demonstrated by us, but many challenges must be solved before clinical adoption. Objectives: Understand the mechanisms determining FFC signals in tissues; Create technology to measure and correct for environmental magnetic fields, enabling FFC at ultra-low fields; Investigate contrast agents for FFC, to increase sensitivity and to allow molecular imaging; Improve FFC technology, in order to extend its range of clinical applications; Test FFC-MRI on tissue samples and on patients. Achieved by: Developing the theory of relaxation in tissue at ultra-low fields, leading to models and biomarkers; Developing magnetometers for FFC-MRI, and environmental-field correction; Creating and in vitro testing of new FFC contrast agents; studying existing clinical agents for FFC-MRI sensitivity; Improving technology to monitor and stabilise magnetic fields in FFC; improving magnet power supply stability; investigating better radiofrequency coils and acquisition pulse sequences; Testing FFC methods on tissue samples from surgery and tissue banks; proof-of-principle scans on patients. FFC-MRI is a paradigm-shifting technology which will generate new, quantitative disease biomarkers, directly informing and improving clinical diagnosis, treatment decisions and treatment monitoring. Its lower cost contributes to healthcare sustainability. The proposal consolidates the EU lead in FFC technology and uses new concepts from world-leading teams to deliver solutions based on innovations in theory, modelling, physics, chemistry and engineering.

Agency: European Commission | Branch: H2020 | Program: CSA | Phase: MSCA-NIGHT-2016 | Award Amount: 144.70K | Year: 2016

Marie Curie once said I am among those who think that science has great beauty. If you wish to explore this beauty you dont need a PhD, yet very welcome is a great deal of curiosity, imagination and a fine handful of patience. Then, just follow your scientific passion and join us at Fusion2Night and play a researcher for a Night or... more! In September 2016 and 2017 Institute of Animal Reproduction & Food Research, University of Warmia&Mazury, and JR School of Higher Education will change Olsztyn into the arena for bonding of researchers and general public, combination of education and entertainment, partnership of academic and industrial centres, and fusion of science disciplines. The topics will range from cutting edge research to unusual perspectives on science, including technology of 7D cinema, neuroscience behind therapy fairytales and pocket-fitting tests on celiac disease. From the morning hours, in a myriad of edutaining activities spread over the entire City, people of all ages will experience how every aspect of our life is possible thanks to scientific influences. With the rule: Tell me and Ill forget. Show me and Ill remember. Let me do and Ill understand!, we will invite kids to try their hands at mind-exciting experiments and see how cool science is. Young people about to embark on career will have a chance to interact with and have their curiosity ignited by scientists, seeing them as ordinary people with extraordinary job. The stereotypic image of a scientist-alienated and immersed in intellectual puzzles having no bearing on others lives-will be confronted with inspiring academic and industry experts, communicating tangible benefits of their research and showing how rewarding science careers are. During face-to-face meetings at EU corner, researchers will promote the MSCA action as a passport to successful scientific career, stimulating pupils to consider their future in science and hence have a chance to co-create the world we all live in.

Agency: European Commission | Branch: H2020 | Program: CSA | Phase: LCE-19-2015 | Award Amount: 499.92K | Year: 2016

The objective of the project Research Coordination for a Low-Cost Biomethane Production at Small and Medium Scale Applications, short Record Biomap, is to establish the most promising innovative process and technology solutions along the biomethane supply chain, from raw material/residues, substrate pre-treatment, digestion, gas conditioning/digestate further utilisation and digestate/fertilizer deployment for a cost and energy sufficient biomethane production and to support their development up to market uptake. To bridge the gap between research and market, a biomethane platform will be established to support the dissemination and exploitation of the knowledge ascertained in the project to the industry sector, the end users and other important stakeholders, and therefore to foster the use of research outcomes. An R&D strategy will lead the way forward into new project concepts. Answering to the scope of LCE 19-2014/2015 of the call of Competitive Low-Carbon Energy in the Horizon2020 work program, the wider goal of Record Biomap will be to accelerate innovation in small to medium scale biomethane production and therefore shorten the time to market of technology solutions which currently have the technical readiness level (TRL) of 3 to 5. The objectives of Record Biomap can be summarised as following: - Accelerate innovation and creation of an European market for small to medium scale biomethane supply through innovative technology and process solutions - Continuous R&D monitoring to bridge the gap between independent technology developers - Continuous knowledge transfer from science to market and policy decision makers and vice verca through building up a biomethane platform for intensive networking - Identification of different sources of private and public financing and bringing together of relevant stakeholders for a continuative development of a more cost and and energy efficient biomethane production at small to medium scale applications.

Duchnowski R.,University of Warmia and Mazury
Journal of Geodesy | Year: 2013

This paper presents new variants of the Hodges-Lehmann estimates, which belong to the class of R-estimates. The new approach to this method arises from the need of taking into account differences in accuracy of geodetic measurements, which is not possible while applying traditional R -estimates. The theoretical assumptions of the conventional Hodges-Lehmann estimates are supplemented with the information about the accuracy of observations and two new variants of the estimates in question are derived by applying the principles proposed by Hodges and Lehmann, hence they are called the Hodges-Lehmann weighted estimate. The main properties of the new estimates follow from such approach, and from the practical point of view, the most important seems to be their robustness against outliers. Since the first estimate proposed is a natural estimator of the shift between two samples, it can be applied in deformation analysis to estimate point displacements. The paper presents two numerical examples that show the properties as well as possible applications of the new estimates. © 2013 The Author(s).

Loading University of Warmia and Mazury collaborators
Loading University of Warmia and Mazury collaborators